INTRODUCTION {#SEC1}
============

The perpetual increase of antibiotic resistant strains among bacterial pathogens represents one of the most imminent challenges to human healthcare in the 21st century, annually accounting for estimated 700 000 deaths worldwide ([@B1]). Horizontal gene transfer (HGT) drives the spread of antibiotic resistances even among unrelated bacteria and conjugative plasmids are major players in this dissemination process. During conjugative transfer, single-stranded (ss) plasmid DNA, coding for antibiotic resistance genes, is conveyed from a donor to a recipient cell via direct cell-to-cell contact. The transferred DNA also encodes the conjugation machinery that in turn enables the recipient to further spread the plasmid DNA. The passage of ss-plasmid DNA across bacterial borders is carried out by a type IV secretion (T4S) conjugative machinery, consisting of three major parts: the relaxosome, the coupling protein and the mating pair formation (MPF) complex, a membrane-spanning multi-protein channel ([@B2]).

Despite Gram-positive (G+) bacterial species belonging to the most health-threatening antibiotic-resistant bacteria worldwide ([@B1],[@B3]), their respective T4S mechanisms are not completely understood to date ([@B4]). Plasmids that have been frequently isolated in bacterial strains associated with nosocomial infections often belong to the incompatibility group 18 (Inc18) represented by G+ plasmids with an exceptional broad host-range, such as pRE25, pSM19035, pAMß1 and pIP501 ([@B5],[@B6]). Inc18 plasmids confer resistance to numerous classes of antibiotics such as the macrolide-lincosamide-streptogramin (MLS) group of antibiotics and pIP501 further codes for chloramphenicol resistance. These broad host-range plasmids are important key players in mediating transfer of resistance genes from *Enterococci* to several multi-drug resistant bacterial strains. The ability of *Enterococcus faecalis* and *Enterococcus faecium* strains to acquire and disseminate mobile genetic elements encoding beneficial traits, among them resistance to last-line antibiotics, further contributed to their manifestation as leading hospital pathogens ([@B5],[@B7]). Broad host-range Inc18 family plasmids were observed to confer resistance to the last-line antibiotic drug vancomycin to strains of methicillin-resistant *Staphylococcus aureus* (MRSA) ([@B8],[@B9]). Nonetheless, research is just beginning to understand determinants facilitating the transfer of Inc18 plasmids.

Due to its small size and simplicity, pIP501 has become a paradigm to study conjugation of Inc18-like broad host-range plasmids in G+ bacteria. This plasmid was originally isolated from *Streptococcus agalactiae* ([@B10]) and the region responsible for conjugative transfer was identified as a single operon of ∼14 kb, encoding 15 transfer (*tra*) genes, *traA* to *traO* ([@B11],[@B12]). The *tra-*operon was observed to be co-transcribed and the mRNA levels remained unchanged during growth ([@B13]). The relaxase TraA is encoded by the first gene of the *tra*-operon and was demonstrated to negatively autoregulate *tra*-gene transcription upon binding to the P*~tra~* promoter ([@B13],[@B14]). Such sophisticated autoregulation systems have been discovered in many plasmids and represent efficient mechanisms to ensure the optimal balance between the lowest effort for the cell and the maximum transfer capacity. Nevertheless, producing these multi-component transfer systems consumes a lot of energy and thus, the expression and assembly of the multi-protein conjugation machineries need to be regulated ([@B15]). To that end, additional regulatory circuits involving accessory factors might be required to ensure the highest possible adaptation to an ever-changing environment.

In this work, we establish the small cytosolic protein TraN as a novel repressor of the pIP501 encoded type IV secretion system (T4SS). We present the 1.9 Å co-crystal structure of TraN bound to its cognate 34 bp binding site DNA, enabling a detailed analysis to identify the precise binding motif. The protein--DNA co-crystal structure confirmed the postulated binding mode of TraN as a variation of the classic helix-turn-helix (HTH) motif. We could demonstrate that binding of TraN to its cognate binding site leads to a significant reduction of promoter activity. Furthermore, we observed elevated mRNA and steady-state protein levels of all tested *tra*-operon components, including the proposed MPF complex member TraM, in an *E. faecalis traN* deletion strain. These transcriptional changes were accompanied by highly increased transfer frequencies, suggesting that TraN is not only an essential factor for the pIP501 encoded T4SS, but also a novel repressor of this conjugative system. All observed phenotypical effects of the knockout mutant could be reversed by overexpression of TraN *in trans*. Moreover, we identified a second specific TraN binding site on the pIP501 plasmid, regulating an active promoter upstream of the *traN* gene. Additional potential TraN binding sites are present on several Inc18-like and other related multi-resistance plasmids, suggesting TraN as a potential pharmacological target to combat the problem of rising antibiotic resistances among bacteria.

MATERIALS AND METHODS {#SEC2}
=====================

Strains and cloning procedures {#SEC2-1}
------------------------------

All bacterial strains and plasmids used in this work are listed in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}. If not stated otherwise, all *E. faecalis* strains were grown in brain heart infusion (BHI, Sigma-Aldrich) medium and used *Escherichia coli* strains were grown in Luria-Bertani (LB, Roth) medium at 37°C and 180 rpm, supplemented with appropriate antibiotics. For all experiments with *E. faecalis*, cells were grown overnight at 37°C and the initial cultures were inoculated to an optical density of OD~600~ = 0.01. Cultures were harvested at mid-exponential phase (reaching an OD~600~ of ∼1.5) and harvested by centrifugation (1 min; 16 100 g; 4°C). Oligonucleotides used in this study are listed in [Supplementary Table S2](#sup1){ref-type="supplementary-material"}.

Co-crystallization of TraN with DNA {#SEC2-2}
-----------------------------------

Expression and purification of TraN was performed as described in ([@B16]). TraN was set up for co-crystallization with double-stranded (ds) oligonucleotides. The ds-oligonucleotides were ordered as desalted ss-oligonucleotides and annealed by heating up equimolar amounts to 95°C for 10 min, followed by slow cooling down to room temperature (RT). The DNA represents the 34 bp binding site as described in ([@B16]) with blunt ends. In all setups, TraN was used with a protein stock concentration of 1.85 mg/ml and premixed with the DNA at a molar ratio of 1.1:1. The plates had a drop volume of 1 μl with a drop ratio of 50% (v/v). Crystals from TraN set up with DNA were harvested from the Index screen (Hampton research) condition 88 (0.2 M ammonium citrate tribasic pH 7.0; 20% (w/v) PEG-3350).

Data collection, processing and refinement {#SEC2-3}
------------------------------------------

Data collection was performed at 100 K on the synchrotron beamline ID29 (ESRF, Grenoble, France) ([@B17]) with a Pilatus 6M detector and a wavelength of 0.97625. All details regarding data collection, phasing and refinement statistics are given in Table [1](#tbl1){ref-type="table"}. A crystal-to-detector distance of 389 mm, an oscillation range of 0.1° and an exposure time of 0.0371 s per image were chosen. In total, 3000 images were collected. The data set was processed and scaled using XDS ([@B18]) and AIMLESS ([@B19]). The 3D-DART webserver ([@B20]) was utilized to generate a search model of the oligonucleotide for molecular replacement. Molecular replacement was first performed with the program PHASER ([@B21]) of the PHENIX software suite ([@B22]), using the recently published structure of TraN (4P0Z; ([@B16])) as a template. A first model with a very limited DNA fragment was refined with REFMAC5 ([@B23]) and used as a template for a second run with PHASER. The resulting model was subjected to the PHENIX program AutoBuild ([@B24]). The model was completed manually in Coot ([@B25]), refined with phenix.refine ([@B26]) and validated by the MolProbity server ([@B27]), resulting in a score of 1.49 (96th percentile). The Ramachandran-plot statistics showed 98.23% favored and no Ramachandran-outliers. 2.83% rotamer outliers occur in the structure. The final coordinates and structure factor amplitudes of the TraN-DNA co-crystal structures have been deposited in the PDB: 6G1T. The PDBePISA server ([@B28]) was used to calculate the interaction surfaces and the solvation energy of TraN and the two oligonucleotides forming the ds-binding site DNA. The CURVES+ server was utilized to analyze the axis bend and the displacement of the DNA molecule ([@B29]).

###### 

Data collection and refinement statistics. Values in parentheses are for the highest-resolution shell

  TraN-DNA structure (6G1T)    
  ---------------------------- --------------------------
  [**Data collection**]{.ul}   
  Space group                  *C*2
  Cell dimensions              
  *a, b, c* (Å)                122.77, 44.17, 56.46
  α, β, γ (°)                  90, 90.86, 90
  Resolution (Å)               41.87--1.93 (2.00--1.93)
  *R* ~merge~                  0.08 (0.675)
  *I* / σ*I*                   12.9 (2.4)
  Completeness (%)             99.6 (99.4)
  Redundancy                   5.6 (5.6)
  **[Refinement]{.ul}**        
  Resolution (Å)               1.93
  No. reflections              22 268
  *R* ~work~/*R*~free~         0.1809/0.2125
  No. atoms                    
  Protein                      976
  Ligand/ion                   15
  Water                        121
  *B*-factors                  
  Protein                      23.90
  Ligand/ion                   29.12
  Water                        31.63
  R.m.s. deviations            
  Bond lengths (Å)             0.009
  Bond angles (°)              1.195

Circular dichroism measurements {#SEC2-4}
-------------------------------

Circular dichroism (CD) measurements were conducted on a Jasco J715 spectropolarimeter (Jasco). Temperature scans ranging from 25°C to 95°C with a temperature slope of 1°C/min were performed in a 0.02 cm cuvette with a protein concentration of 0.3 mg/ml mixed with ds-DNA oligonucleotides (sequences are given in [Supplementary Table S3](#sup1){ref-type="supplementary-material"}) in a 1:1 molar ratio when required. The upscan was performed with a starting temperature of 25°C and an end temperature of 95°C and the downscan was performed from 95°C back to 25°C. Full spectra from 190 to 260 nm were recorded every 5°C and calculations were performed utilizing the SpectraManager Software (Version 1.08.01). The secondary structure composition of selected spectra from the temperature scans (25°C, upscan; 95°C; 25°C, downscan) were analyzed with the DicroWeb server ([@B30],[@B31]) with the same parameters as used in ([@B16]).

Differential scanning fluorimetry assays {#SEC2-5}
----------------------------------------

ss-DNA oligonucleotides with a concentration of 100 pmol/μl were treated as described in the crystallization section (sequences are given in [Supplementary Table S3](#sup1){ref-type="supplementary-material"}). 5 μl of TraN (1.9 mg/ml) was mixed with ds-DNA oligonucleotides in a 1:1 molar ratio. 5 μl of buffer (25 mM HEPES; 75 mM Na~2~SO~4~; pH 7.6) was added, the reaction volume was stocked up to 20 μl with distilled water and 5 μl of 50× SYPRO Orange (Sigma-Aldrich) was admixed. After incubation at RT for 5 min, the melting curve was measured from 25°C to 95°C in increments of 0.1°C and with 6 s incubation time at every step with a CFX96 Real-Time PCR Detection System (Bio-Rad).

Analysis of promoter activity {#SEC2-6}
-----------------------------

To assess the activity of the original pIP501 P*~tra~* promoter in *E. coli*, the β-galactosidase gene from the promoter-probe plasmid pQF120 was set under the control of the P*~tra~* promoter with (pQF120_oBS_P*~tra~*) and without the original TraN binding site, o BS, (pQF120_P*~tra~*) present, as described elsewhere ([@B13]). For activity determination of the newly identified promoter P*~traNO~*, the promoter sequence with (pQF120_BS3_P*~traNO~*) or without (pQF120_P*~traNO~*) the alternative binding site BS 3 was cloned into pQF120. A second plasmid either used as empty vector control (pET28a_p15) or harboring TraN (pET28a_p15\_*traN*) or the control protein T25 (used in Figure [4A](#F4){ref-type="fig"}), a fragment of the adenylate cyclase (pET28a_p15\_*T25*), was co-expressed. *E. coli* JM109 carrying variants of the two plasmids pQF120 and pET28a_p15 was grown at 30°C. Two hours after induction with 1 mM IPTG, a β-galactosidase assay, adapted from ([@B32]), was performed. The absorption at 405 and 600 nm was measured with a TECAN GENios Pro plate reader and relative Miller units were calculated.

Construction of a markerless *traN* knockout mutant and a TraN overexpression plasmid for complementation {#SEC2-7}
---------------------------------------------------------------------------------------------------------

A pIP501 *traN* in-frame deletion mutant in *E. faecalis* JH2--2 (pIP501Δ*traN*) was generated using a method consisting of two homologous recombination steps as described in ([@B33]). 95% of *traN* was deleted, maintaining the two N-terminal and the four C-terminal codons intact to avoid polar effects on downstream genes in the pIP501 *tra-*operon. The knockout was confirmed by sequencing. To complement the knockout phenotype, the *traN* gene with an optimized ribosomal binding site was cloned into pEU327 ([@B34]) and the overexpression plasmid was transformed into the *traN* deletion strain.

Biparental mating assays {#SEC2-8}
------------------------

Filter mating experiments with *E. faecalis* OG1X as recipient were employed as described previously ([@B35]). Transfer rates of three independent experiments are given.

Assessment of growth and cellular viability {#SEC2-9}
-------------------------------------------

To analyze and compare growth of *E. faecalis* JH2--2 (negative control) with the *E. faecalis* JH2--2 wild type (pIP501) and mutant (pIP501Δ*traN*) strain, cells were inoculated to OD~600~ = 0.01 and OD~600~ was assessed every 30 min for 7.5 h on a Beckman coulter DU 730 Life Science UV/VIS Spectrophotometer.

Loss of membrane integrity indicated via propidium iodide (PI) staining was utilized to analyze cellular viability at distinct time points. 100--200 μl (depending on optical density) of culture was harvested by centrifugation (1 min; 16 100 g; 4°C) and resuspended in 250 μl phosphate buffered saline (PBS; 25 mM potassium phosphate; 0.9% (w/v) NaCl; pH 7.2) containing 100 μg/l PI. After 10 min incubation in the dark at RT, cells were washed once with 250 μl PBS. 30 000 cells per sample were analyzed with flow cytometry (BD LSR Fortessa; BD FACSDivia software).

SDS-PAGE and immunoblotting {#SEC2-10}
---------------------------

For determination of steady-state protein levels and comparison between negative control, wild type (pIP501), knockout (pIP501Δ*traN*) and complementation (pIP501Δ*traN*, pEU327-*traN*) strain, *E. faecalis* JH2-2 samples were resuspended in lysis buffer (1× PBS pH 7.2; 1 mM PMSF; 1 mM benzamidine) and sonicated for 30 s (Sonopuls, HD 2070, Bandelin; 60% amplitude, 0.5 s pulses). After addition of SDS sample buffer and incubation for 10 min at 95°C, samples were centrifuged (1 min; 16 100 g; RT). The supernatant was loaded onto a SDS-polyacrylamide-gel, separated by electrophoresis and blotted onto a PVDF membrane (ROTH) using wet electro-transfer. Blots were probed with primary polyclonal rabbit antibodies against Tra-proteins (dilution 1:10 000; Biogenes GmbH, Berlin) or monoclonal antibodies against EF-Tu (dilution 1:10 000; mouse, Hycult Biotech, HM6010) and GroEL (dilution 1:10 000; rabbit, Sigma-Aldrich, G6532) and the respective secondary antibodies (goat anti-mouse, Thermo Scientific, 31430; goat anti-rabbit, Promega, W4011; both horseradish-peroxidase conjugated; dilution 1:20 000). Immunodetection was performed using an ECL kit from GE Healthcare on a Chemidoc™ Touch Imaging System (Bio-Rad). For analysis of steady-state protein expression levels, the blots were stripped and re-probed with GroEL and EF-Tu used as loading controls. Densitometric quantification was performed utilizing Image Lab 5.2 software (Bio-Rad).

Quantitative real-time PCR {#SEC2-11}
--------------------------

For expression analysis on transcriptional level of the wild type (pIP501), knockout (pIP501Δ*traN*) and complementation (pIP501Δ*traN*, pEU327-*traN*) strain, samples of OD~600~ = 1 were harvested (1 min; 16 100 g; 4°C) and total RNA was isolated using TRIzol reagent (Thermo Scientific). Briefly, the cell pellets were resuspended in 500 μl TRIzol plus approximately 200 μl glass beads (500 μm diameter) and mechanical lysis was performed in three cycles of 1 min with 4000 g (PowerLyzer^®^ 24 Bench Top Bead-Based Homogenizer, Qiagen). The following steps were employed as described in the manufacturer\'s manual. Integrity of the isolated RNA was validated by visualizing rRNAs using an agarose gel-electrophoresis protocol adapted from ([@B36]). Contaminating DNA was removed with the DNA-free Kit (Ambion) and the RNA concentration was determined spectrometrically with a NanoDrop (ND 1000 Spectrophotometer). 2 μg of total RNA were reverse transcribed using the M-MLV Reverse Transcriptase RNase H- (Solis Biodyne) and random hexamer primers (Thermo Scientific). The actual q-RT-PCR was performed with the 5× HOT FIREPol EvaGreen qPCR Supermix (Solis Biodyne) as described in the manual. First, standard curve experiments were performed to ensure primer efficiency lying between 90% and 110%. The actual runs were accomplished in quadruplicate. Pyrroline-5-carboxylate reductase (*proC)* and glyceraldehyde-3-phosphate dehydrogenase (*gapdh)* were used as housekeeping genes and gene expression of *proC* was utilized to calculate the relative gene expression levels with the comparative C~T~ method (ΔΔC~T~ method ([@B37])).

Immunolabeling of TraM in *E. faecalis* {#SEC2-12}
---------------------------------------

For visualization of TraM in *E. faecalis* JH2-2 wild type (pIP501) and the knockout (pIP501Δ*traN*) strain with *E. faecalis* JH2-2 as negative control, we applied a recently established immunostaining method ([@B38]), using a TraM specific primary antibody (dilution 1:50; Biogenes GmbH, Berlin) and an Alexa-594 conjugated secondary antibody (dilution 1:100; goat anti-rabbit, Thermo Scientific, R37117), combined with MDY-64 (Thermo Scientific) counterstaining of the cytosol, enabling us to discriminate between bacterial cells and background. To only visualize correctly localized TraM molecules at the cell membrane, the fixing and the digestion time were reduced (fixation for 30 min followed by enzymatic digestion of the cell wall for 10 min), no permeabilization step was included and no detergent was added to the buffers.

Analysis of TraM fluorescence signal with confocal microscopy and flow cytometry {#SEC2-13}
--------------------------------------------------------------------------------

In all experiments, immunolabeled cells were immobilized on agar slides and visualized with a Leica SP5 confocal microscope, with spectral detection and a HCX PL APO 63× NA 1.4 oil immersion objective. MDY-64 was excited at 488 nm and emission was detected between 500 and 530 nm. For Alexa-594 detection, excitation was performed at 561 nm and emission was detected between 580 and 630 nm. Pictures were subsequently processed and analyzed using the open-source software FIJI ([@B39]). In all experiments Z-stacks using 63 × 63 × 125 (*x/y/z*) nm sampling were acquired and subsequently Z-projections with the maximum-intensity projection method were performed for all channels. To measure the fraction area of imaged TraM structures per cell, MDY-64 stained cells in intensity projections were segmented using the Otsu-method, while excluding not fully acquired objects at the image borders. Pictures were subsequently transformed to binary images and the watershed method was applied to separate cells in close proximity. Individual segmented cells were afterwards added to the region of interest (ROI) manager with the analyze particles function. These ROIs were used to measure the fraction area of structures in respective TraM-fluorescence channels. Six independent measurements (*n* = 6) were conducted and 527 (negative), 317 (pIP501) and 306 (pIP501Δ*traN)* cells in total were analyzed. To quantify the fluorescence signal intensity of TraM, the measurements were conducted with a single-photon detector. For computation of the intensity of fluorescently labeled TraM structures, pictures were segmented as described above. The mean grey value of each TraM particle was measured using the analyze particles function and the fluorescence intensity per pixel is presented as fold of wild type (pIP501). Five independent measurements (*n* = 5) with 1576 (pIP501) and 1250 (pIP501Δ*traN*) cells in total were analyzed. In addition to greyscale images, a spectrum look-up table was applied to easier appreciate intensity differences. Brightness and contrast were adjusted in representative pictures. All pictures within an experiment were processed equally.

For flow cytometry, samples were immunostained as described above and each strain was analyzed in quadruplicate with a flow cytometer (BD LSR Fortessa) and the mean fluorescent intensity of 30 000 cells per sample was determined with BD FACSDivia software. To avoid artefacts from background signals (e.g. autofluorescence), the values for fluorescence intensity of the negative strain were subtracted from wild type and mutant strain prior to calculation.

Search for similar binding sites and promoter motifs {#SEC2-14}
----------------------------------------------------

To analyze whether related plasmids or bacterial strains also harbor a TraN binding motif, we initially conducted a BLAST search ([@B40]) for potential *traN*-gene homologs and further tested if those also carry homologs coding for the relaxase TraA and the motor proteins TraE and TraJ. To search for similar binding sites, the respective sequences were analyzed with the SnapGene viewer software (BSL Biotech LLC, version 4.1.4) and the search function, where individual bases can be set as ambiguous, was applied. Three different search terms were used: (i) Original binding site, o BS (A~6~T~7~G~8~T~9~C~10~A~11~G~12~G~13~T~14~T~15~A~16~A~17~A~18~C~19~A~20~T~21~A~22~ T~23~); (ii) Binding site involving class (I) interactions (N~6~T~7~G~8~N~9~C~10~N~11~N~12~N~13~N~14~N~15~A~16~N~17~A~18~C~19~A~20~T~21~ N~22~N~23~); (iii) Binding site with nucleotides required for TraN specificity (N~6~T~7~G~8~T~9~C~10~A/T~11~N~12~N~13~T~14~N~15~A~16~A~17~A~18~C~19~A~20~T~21~N~22~T~23~). The identified potential binding sites were further characterized by investigating adjacent stretches for the presence of a promoter. Where annotated, the sequence of the origin of transfer (*oriT*) is given. Otherwise, *in silico* prediction of the *oriT* according to the consensus sequence identified in ([@B41]) was made. The protein identity of Tra-protein homologs was calculated with Clustal Omega ([@B42]).

Statistics {#SEC2-15}
----------

Results are visualized either as line graphs showing mean ± standard error of mean (s.e.m.), dot plots (if *n* \< 8) where mean (square), median (center line) and s.e.m are depicted, or as box plots (if *n* ≥ 8) with mean (square) and median (center line) as well as whiskers presenting minima and maxima within 2.2 interquartile range (IQR). Student\'s t-test (applied for Figures [5A](#F5){ref-type="fig"}, [C](#F5){ref-type="fig"}, [7C](#F7){ref-type="fig"}, [Supplementary Figure S5B](#sup1){ref-type="supplementary-material"}) and analysis of variance (ANOVA) with a Bonferroni post hoc test (applied for Figure [4A](#F4){ref-type="fig"}) were used to compare between two or multiple groups, respectively, and displayed significances are two-sided (calculated with Origin Pro 2016, OriginLab). Normal distribution of data was examined with a Shapiro-Wilk\'s test and homogeneity of variances was confirmed with a Levene\'s test (both analyzed with Origin Pro 2016). In case of heterogeneous variances, a Welch\'s *t*-test (applied for Figure [4B](#F4){ref-type="fig"}, [D](#F4){ref-type="fig"}, calculated with Origin Pro 2016) or a Welch\'s ANOVA with a Games-Howell post hoc test (applied for Figures [6A](#F6){ref-type="fig"}, [B](#F6){ref-type="fig"}, [D](#F6){ref-type="fig"}, [7A](#F7){ref-type="fig"}, [B](#F7){ref-type="fig"}, [Supplementary Figure S6B](#sup1){ref-type="supplementary-material"}, calculated with IBM SPSS Statistics, Version 24) was used. Outliers were identified using the 2.2-fold IQR labeling rule and were only detected in Figure [3B](#F3){ref-type="fig"} (indicated with magenta diamonds). Outlier containing data was analyzed using a nonparametric Kruskal--Wallis test, calculated with IBM SPSS Statistics, Version 24. For the assessment of viability of different strains (negative, pIP501 and pIP501Δ*traN*; = between-subject factor) over time (within-subject factor), a two-way ANOVA mixed design with a Bonferroni post hoc test was applied ([Supplementary Figure S4B](#sup1){ref-type="supplementary-material"}; conducted with Origin Pro 2016). Significances are indicated with asterisks: \*\*\**P \<* 0.001, \*\**P* \< 0.01, \**P* \< 0.05, n.s. not significant. All figures were processed with Origin Pro 2016 and Adobe Illustrator CS6 (Adobe).

RESULTS {#SEC3}
=======

The TraN-DNA co-crystal structure gives detailed insights into the binding mode {#SEC3-1}
-------------------------------------------------------------------------------

Recently, we solved the atomic structure of TraN and experimentally identified its approximate binding site location on the pIP501 plasmid ([@B16]). To get detailed insights into TraN's mode of action on the molecular level, oligonucleotides comprising the proposed binding site were set up with TraN in protein--DNA co-crystallization trials. We obtained crystals of a 1:1 complex of TraN with a 34-mer double-stranded (ds) oligonucleotide, which contained one complex per asymmetric unit and diffracted to 1.93 Å (Table [1](#tbl1){ref-type="table"}).

The structure is well ordered except for the N-terminal methionine and six residues at the C-terminal end of TraN, which were not observed in the final electron density map. In addition, five nucleotides at the 3′-end of the forward strand (D-strand) and two nucleotides at the 5′-end of the reverse strand (E-strand) exhibited low electron density due to apparent flexibility. TraN shows an internal dimer fold with an α--β composition comprising of 9 α-helices (h1--h9) and 6 β-strands (s1--s6) (Figure [1A](#F1){ref-type="fig"}, for details on the secondary structure elements, see Figure [2E](#F2){ref-type="fig"}). Helices 3 and 7 represent the recognition helices of two helix-turn-helix (HTH) motifs, constituting the N- and the C-terminal domains of TraN. The β-strands in the center of the protein form a β-barrel-like motif at the internal dimer axis. The co-crystal structure presented in this study confirms the postulated binding mode of TraN: A winged-helix (WH) protein--DNA interaction, a common variation of the classic HTH-motif ([@B43]) (Figure [1A](#F1){ref-type="fig"}). The recognition helices h3 and h7 of the TraN internal dimer HTH-domains indeed reach into two adjacent major grooves of the binding site of the ds-oligonucleotide (Figure [1A](#F1){ref-type="fig"}). Both wings of the WH-motif consisting of the β-strands s2 and s3 of the N-terminal domain and s5 and s6 of the C-terminal domain, respectively, protrude into the central minor groove of the binding site and are involved in numerous direct or indirect DNA interactions. This arrangement is in significant contrast to the DNA binding mode of homo-dimeric WH transcription factors, such as the LysR-type transcriptional regulators, where the wing of each WH-motif contacts the distal minor groove ([@B47]).

![TraN shows highly specific interaction with its cognate binding site. (**A**) Cartoon representation of TraN bound to the double-stranded (ds) oligonucleotide comprising the specific binding site (forward strand/D-strand; reverse strand/E-strand). Front view and rotated by 180° around the vertical axis are depicted. Amino acids involved in specific interaction with the DNA are shown as cyan sticks. (**B**, **C**) Calculation of the axis bend by the CURVES+ server ([@B29]). (B) The trajectory of the DNA helix is drawn as a black line over the ds-oligonucleotide and the bend of the DNA is given. (C) The axis bend of the forward/D-strand from C~1~ to T~29~ is depicted with the TraN binding region shaded in grey. (**D**) Surface representation of the electrostatic potential of TraN with the binding site DNA slightly elevated from the protein. Only nucleotides involved in the direct interaction are colored. Front view and rotated by 180° around the vertical axis are depicted.](gky671fig1){#F1}

![Interactions of TraN with the DNA lead to highly specific binding. **(A--C)** Class (I) interactions between amino acid side chains and DNA bases are depicted. Interactions of the N-terminal half of TraN (A), the C-terminal half of TraN (B) and the second loop protruding into the minor groove of the DNA (C) are shown with important amino acids and bases highlighted in color. Coordinated water molecules are depicted as spheres. The forward / D-strand and/or the reverse/E-strand are labeled. (**D**) Sequence of the double-stranded (ds) oligonucleotides used in the crystallization trials, the nucleotides visible in the X-ray structure are marked with square brackets. A dashed line indicates the pseudo-2-fold axis of the imperfect inverted binding site repeats. All nucleotides interacting with TraN are shaded in grey. Direct base to side chain interactions (class (I)) are highlighted in magenta and bases which are part of class (II) interactions (between either amino acid side chains or peptide backbone with the DNA backbone) are marked with an asterisk. Class (III) water-mediated interactions are indicated with a blue dot and van-der-Waals interactions with a circle in magenta. An alternative labeling according to the base pair position of L39769.1 is given. (**E**) Sequence and secondary structure-based alignment of the two TraN domains. Secondary-structure elements are labeled, identical amino acids are shaded in grey. Class (I) interactions are highlighted in magenta, class (II) interactions with an asterisk, class (III) interactions are marked with a blue dot and van-der-Waals interactions with a circle in magenta.](gky671fig2){#F2}

When comparing the complex structure of TraN with the previously published apo-form, no significant differences regarding the fold of the protein were observed (RMSD of 0.6 Å). However, the complex formation leads to a significant deformation of the B-form DNA, introducing an overall bend of 32.4° (Figure [1B](#F1){ref-type="fig"}) that is localized at the contact positions with the two recognition helices h3 and h7 (Figure [1C](#F1){ref-type="fig"}). This causes a displacement of the base pairs in these areas away from the helical axis ([Supplementary Figure S1A, B](#sup1){ref-type="supplementary-material"}) and consequently a significant widening of the major groove at the binding sites, resulting in a compression of the adjacent minor grooves. DNA bending assays using an electrophoretic mobility shift assay (EMSA) approach did not reveal significant bending of the DNA under the conditions tested (data not shown), which might be caused by a compensation of the local bends in the neighboring regions.

Due to the positive charge of the TraN surface facing the ds-DNA, a close interplay with the phosphate groups of the DNA backbone can be observed (Figure [1D](#F1){ref-type="fig"}). An exception is the surface area of the loop connecting the α-helices h6 and h7 of the C-terminal HTH-motif (Figure [1D](#F1){ref-type="fig"}), where two negatively charged residues (Asp-77 and Glu-78) are replacing a positively charged and a neutral residue (Arg-23 and Asn-24) when compared to the N-terminal domain (Figure [1D](#F1){ref-type="fig"} and [Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}; for details on the alignment, see Figure [2E](#F2){ref-type="fig"}). The buried interaction surface of TraN with the ds-DNA amounts to 883 and 850 Å^2^ for forward (D-strand) and reverse (E-strand) strand, respectively. Due to overlapping areas, the total buried interaction surface is slightly smaller with 1660 Å^2^. These values are similar to the protein--DNA interaction surface of the MerR family of transcriptional regulators ([@B48]). MerR-like proteins share a similar WH-fold with TraN and bind to their designated binding sites as dimers, reminiscent of the internal dimer composition of TraN (e.g. MerR-like protein MtaN from *Bacillus subtilis*, PDB: 1R8D; 1679 Å^2^ of protein--DNA interaction surface). Due to this structural similarity, a potential role of TraN as a regulator of the pIP501 encoded T4SS was proposed ([@B16]).

The specificity of TraN DNA-binding depends on a distinct motif {#SEC3-2}
---------------------------------------------------------------

The polar interactions fall into three classes: (I) interactions between distinct amino acid side chains and the bases of the DNA, (II) interactions concerning either the amino acid side chains (IIa) or the protein backbone (IIb) with the backbone of the DNA and (III) water-mediated interactions ([Supplementary Table S4](#sup1){ref-type="supplementary-material"}). Sequence specific interactions (class (I)) are mediated by Arg-23, Asn-24 and Gln-28 of the N-terminal domain forming hydrogen bonds (H-bonds) to the bases in the right half site (Figure [2A](#F2){ref-type="fig"}) and by Glu-78, His-82 and Arg-86 of the C-terminal domain forming H-bonds to bases in the left half site (Figure [2B](#F2){ref-type="fig"}). In addition to the major groove contacts, the β-hairpins reach into the central minor groove where Lys-101 forms a direct base contact (Figure [2C](#F2){ref-type="fig"}). These interactions are important for the recognition and the strong specific binding of TraN to its binding site (Figure [2D](#F2){ref-type="fig"}, [E](#F2){ref-type="fig"}). Interestingly, van-der-Waals interactions of the C5M-methyl groups of thymine bases with hydrophobic patches of TraN are also contributing to the sequence specificity (Figure [2D](#F2){ref-type="fig"}, [E](#F2){ref-type="fig"} and [Supplementary Figure S2A--C](#sup1){ref-type="supplementary-material"}). This concerns T~15~ of the E-chain forming contacts with the N-terminal domain (especially with Asn-22, Arg-23 and Asn-24; [Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}) and T~7~ (interacting with Phe-87), T~9~ (interacting with Asn-76) of the D-chain ([Supplementary Figure S2B](#sup1){ref-type="supplementary-material"}) and T~24~ of the E-chain (forming contacts with Glu-78, Ala-81 and His-82; [Supplementary Figure S2C](#sup1){ref-type="supplementary-material"}), respectively, interacting with the C-terminal domain. Here, a clear difference between the binding modes of the N- and the C-terminal domains is evident. The asymmetry of the two half sites results in only one hydrophobic patch being in contact with a thymine base in the N-terminal domain ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}), whereas three such patches exist in the C-terminal domain ([Supplementary Figure S2B, C](#sup1){ref-type="supplementary-material"}), indicating a much better complementary fit to the left half site (Figure [2D](#F2){ref-type="fig"}, [E](#F2){ref-type="fig"}). The importance of such hydrophobic patches for the sequence specific DNA recognition has been noted for the structurally related LysR-type transcription regulators ([@B47]).

All interactions are listed in [Supplementary Table S4](#sup1){ref-type="supplementary-material"} and an overview of the amino acids and bases involved in the interplay of TraN with its binding site are depicted in Figure [2D](#F2){ref-type="fig"}, [E](#F2){ref-type="fig"}. Investigating the binding interfaces of the two domains separately using the PDBePISA server ([@B28]) yielded a significant difference in the free energy of assembly dissociation with 7.2 kcal/mol for the N-terminal domain and 10.7 kcal/mol for the C-terminal domain. Together with the observed differences in the van der Waals contacts, these results indicate a stronger interaction of the C-terminal domain of TraN with the DNA compared to the N-terminal domain.

The thermal stability of TraN in the presence or absence of DNA was assessed with circular dichroism (CD) measurements. Without DNA, the full TraN spectrum showed signs of significant unfolding at 95°C, but the protein refolded almost completely when cooled down to 25°C. In comparison the protein is stabilized by complexation with DNA, leading to only a slight conformational change upon heating to 95°C. A similar effect was observed for both the specific binding site and the random sequence, pointing towards a general stabilization of the protein by DNA binding (Figure [3A](#F3){ref-type="fig"}). The secondary structure composition of TraN and its change upon temperature variation was assessed by the DicroWeb server ([@B30],[@B31]) and can be found in [Supplementary Table S5](#sup1){ref-type="supplementary-material"}.

![TraN is stabilized by binding to its specific DNA site. (**A**) Circular dichroism (CD) temperature scans of TraN without DNA, with the original binding site (o BS) DNA as well as with random DNA. Temperature scans were performed with a temperature slope of 1°C per min. The upscan started from 25°C to an end temperature of 95°C and the downscan began at 95°C and cooled down back to 25°C. Full spectra between 190 nm and 260 nm at 25°C before heating to 95°C (black line; 25°C, upscan), at the maximum temperature of 95°C (blue line) and after cooling down to 25°C (gray line; 25°C, downscan) are depicted. θ~mre~ = Molar ellipticity. For secondary structure analysis using the DicroWeb server ([@B30],[@B31]), please see [Supplementary Table S5](#sup1){ref-type="supplementary-material"}. (B) Differential scanning fluorimetry (DSF) assay of TraN without DNA, with random DNA and the original binding site DNA (o BS) as well as with reverse charge (RC) or different spacing (DS) mutations in the upstream (left), downstream (right) and both interaction sites with the melting temperature depicted. Outliers are denoted as magenta diamonds. For 'no DNA' *n* = 16, for all others *n* = 10. Mean (square) and median (center line) are depicted. Whiskers within box plots show minima and maxima within 2.2 interquartile range (IQR). \*\*\**P*\< 0.001.](gky671fig3){#F3}

To examine the significance of the directly interacting bases, we conducted differential scanning fluorimetry (DSF) assays in the presence of mutated oligonucleotides (details on the mutated bases can be found in [Supplementary Table S3](#sup1){ref-type="supplementary-material"} and [Supplementary Figure S3A, B](#sup1){ref-type="supplementary-material"}). The complex with the original binding site (o BS) showed an increase in the melting temperature (T~M~) of 16°C, whereas with random DNA it was 10°C, respectively (Figure [3B](#F3){ref-type="fig"}). Mutations in the individual halves diminished the thermal stability of TraN with a drop in the T~M~ of up to 5°C, being more prominent when the left half binding site (contacted by the C-terminal domain of TraN) was affected (Figure [3B](#F3){ref-type="fig"}). The melting temperature dropped even further when both half sites were mutated simultaneously (Figure [3B](#F3){ref-type="fig"}). Together, these experiments confirm the identified bases as crucial for the specificity of TraN binding and thus represent the actual TraN binding motif.

TraN acts as negative regulator of *tra*-operon components {#SEC3-3}
----------------------------------------------------------

Due to TraN's structural similarity with transcriptional regulators from the MerR family, a potential role of TraN as a regulator of the pIP501 encoded T4SS was proposed ([@B16]). To test this hypothesis, the promoter activity was evaluated in *E. coli* using a reporter plasmid expressing β-galactosidase under the control of the P*~tra~* promoter, with or without the o BS of TraN. A second plasmid encoding either *traN* or selected controls (empty vector control; T25, adenylate cyclase fragment) was supplied *in trans*. Whereas neither the empty vector, nor T25 expression changed β-galactosidase activity when comparing plasmids with or without the binding site, a significant reduction of β-galactosidase activity was observed upon TraN *in trans* expression when the test plasmid harbored o BS (Figure [4A](#F4){ref-type="fig"}). These results clearly indicate that TraN binding to its cognate binding site leads to repression of the P*~tra~* promoter.

![TraN acts as a negative regulator of *tra*-operon components. (**A**) β-galactosidase assay to monitor P*~tra~* promoter activity in *E. coli*. The β-galactosidase gene was set under the control of the P promoter with or without the original TraN binding site (o BS) and TraN or two controls (empty vector and T25, a fragment of the bacterial adenylate cyclase) were supplied *in trans*. Enzymatic activity was assessed in *E. coli* with a β-galactosidase assay and Miller units are given as fold of empty vector control. *n* = 24. (B) Analysis of *tra*-gene mRNA levels in *E. faecalis* JH2-2 wild type (pIP501) and mutant (pIP501Δ*traN*) cells. Pyrroline-5-carboxylate reductase (*proC)* and glyceraldehyde-3-phosphate dehydrogenase (*gapdh)* were used as housekeeping genes. Relative gene expression was calculated applying the comparative C~T~ method (ΔΔC~T~ Method ([@B37])) using *proC* as housekeeping gene and values are given as fold of the respective wild type gene expression. *n* = 4. (C, D) Immunoblot analysis of steady-state protein levels from *E. faecalis* JH2-2 (negative control), *E. faecalis* JH2-2 wild type (pIP501) and mutant (pIP501Δ*traN*) cells. Representative immunoblots (C) and densitometric quantification (D) are shown. Blots were probed with antibodies directed against distinct Tra-proteins and EF-Tu and GroEL as loading controls. Values are given as fold of the respective wild type protein levels. *n* = 12. Mean (square) and median (center line) are depicted. For box plots, whiskers show minima and maxima within 2.2 interquartile range (IQR), for dot plots standard error of mean (s.e.m.) is given. n.s. not significant, \**P*\< 0.05, \*\**P*\< 0.01, \*\*\**P*\< 0.001.](gky671fig4){#F4}

To confirm that TraN also represses the P*~tra~* promoter in the native T4SS environment in *E. faecalis*, a knockout mutant of *traN* was constructed. First, growth and viability of the constructed knockout (pIP501Δ*traN*) was assessed. When measuring optical density, the knockout mutant *E. faecalis* JH2-2 pIP501Δ*traN* displayed delayed growth during exponential phase compared to wild type (pIP501) cells and the negative control *E. faecalis* JH2.2, while still reaching a comparable optical density in stationary phase ([Supplementary Figure S4A](#sup1){ref-type="supplementary-material"}). Flow cytometric analysis of membrane integrity using propidium iodide (PI) showed a significantly increased portion of dead cells in the *traN* knockout mutant when compared to wild type and negative control in both exponential and stationary phase ([Supplementary Figure S4B](#sup1){ref-type="supplementary-material"}). Thus, the lack of *traN* seems to pose an additional burden to the cells, resulting in slightly impeded growth and decreased viability.

To further characterize the deletion mutant, gene expression levels, normalized to pyrroline-5-carboxylate reductase (*proC)* as housekeeping gene using the ΔΔC~T~ Method ([@B37]), were compared between the *E. faecalis* JH2-2 knockout mutant and the wild type strain. mRNA levels of all tested *tra*-genes were significantly upregulated upon deletion of *traN* (Figure [4B](#F4){ref-type="fig"}). When assessing steady-state protein levels using quantitative immunoblotting, all tested Tra-proteins were elevated in the *E. faecalis traN* deletion mutant compared to wild type cells harboring pIP501 (Figure [4C](#F4){ref-type="fig"}, [D](#F4){ref-type="fig"}). Taken together, these results suggest a negative regulation of *tra*-component expression by TraN.

A significant proportion of upregulated TraM localizes correctly in the *traN* deletion mutant {#SEC3-4}
----------------------------------------------------------------------------------------------

Due to the high homology of TraM to VirB8-like proteins ([@B49]) and the fact that TraM was shown to interact with the peptidoglycan-digesting protein TraG---a central key player in the assembly of the MPF complex---([@B38],[@B50]), the expression levels of this essential Tra-protein were further assessed with complementary approaches. Analysis of steady-state protein levels gives insights into the whole expression load at a certain time point but does not discriminate between different protein subpopulations ranging from correctly localized to mislocalized, unfolded and maybe even aggregated protein. To that end, we performed immunostaining of *E. faecalis* JH2-2, either harboring wild type pIP501 or the deletion variant pIP501Δ*traN* with the plasmid-free strain as negative control, using primary anti-TraM specific antibodies and corresponding Alexa-594-labeled secondary antibodies. With this approach, only correctly localized TraM molecules at the cell\'s periphery should show a fluorescence signal since mild conditions without permeabilization steps were applied. 30 000 cells per sample were analyzed with flow cytometry, confirming the upregulation of TraM in the *E. faecalis traN* deletion mutant (Figure [5A](#F5){ref-type="fig"}). To verify this result with a visual approach, the samples were further analyzed with confocal microscopy. Using a single-photon detector, the mean fluorescence signal intensity of \>1200 cells per strain was quantified, confirming the flow cytometric data ([Supplementary Figure S5A, B](#sup1){ref-type="supplementary-material"}). Interestingly, while steady-state protein levels revealed an upregulation of ∼5-fold in the *E. faecalis* knockout strain (pIP501Δ*traN)*, the elevation of the fluorescence signal was ∼1.5-fold. Due to the proposed essential role of TraM in MPF complex assembly ([@B38],[@B49],[@B50]), we next investigated potential changes in the subcellular distribution of TraM upon *traN* deletion. The wild type strain harboring pIP501 and the *traN* knockout mutant revealed a similar localization pattern of TraM in distinct foci at the cell membrane, while the number of foci appeared to be elevated in mutant cells (Figure [5B](#F5){ref-type="fig"}). Aiming to quantify the number of distinct TraM-positive dots, we observed a variable size of these structures, potentially due to their close spatial proximity and the resolution limit of confocal microscopy. To provide quantitative data, we measured the area captured by the TraM signal in individual cells instead. When analyzing at least 300 cells of each strain, we observed an average 1.7-fold increase in the TraM signal area in the *E. faecalis* knockout strain (pIP501Δ*traN*) compared to cells harboring wild type pIP501 (Figure [5C](#F5){ref-type="fig"}). Combining flow cytometry with confocal imaging techniques further confirmed the observed upregulation of TraM in the *E. faecalis* knockout mutant pIP501Δ*traN*. While indicating that not the whole protein load detected with immunoblotting seems to be correctly localized at the cell membrane, still a significant increase of the TraM protein at the cell periphery is detected in the *traN* knockout mutant.

![A significant quantity of overproduced TraM localizes to the cell periphery in the *E. faecalis traN* deletion mutant. (**A**) Flow cytometric analysis of *E. faecalis* JH2-2 wild type (pIP501) and mutant (pIP501Δ*traN*) cells to analyze TraM signal intensities with *E. faecalis* JH2-2 as negative control. Fixed cells were probed with primary TraM-antibodies and corresponding secondary antibodies conjugated with Alexa-594. 30,000 cells per sample were analyzed in quadruplicate with flow cytometry. The signal of the negative strain was subtracted from the TraM-signal of wild type and knockout strain as a background control. The mean fluorescence intensity of the TraM signal is depicted as fold of wild type. *n* = 4. For quantification of TraM fluorescence signal intensity using confocal microscopy techniques, see [Supplementary Figure S5A, B](#sup1){ref-type="supplementary-material"}. (**B, C**) Immunolabeling of *E. faecalis* JH2-2 wild type (pIP501) and the mutant strain *E. faecalis* JH2-2 (pIP501Δ*traN*) with *E. faecalis* JH2-2 as negative control to analyze TraM signal area. Cells were prepared as described in (A). Z-projection of three-dimensional representative micrographs (B) and quantification of the area of TraM spots (C) are displayed. Values are given as fold of the wild type. No fraction area of the negative strain was detectable. Six independent measurements (*n* = 6) with 527 (negative), 317 (pIP501) and 306 (pIP501Δ*traN*) cells in total were analyzed. Scale bar represents 2 μm. Mean (square) and median (center line) are depicted. For dot plots standard error of mean (s.e.m.) is given. \*\*\**P*\< 0.001.](gky671fig5){#F5}

Deletion of *traN* increases the frequency of conjugative transfer {#SEC3-5}
------------------------------------------------------------------

Finally, we investigated whether the elevated expression level of *tra*-components results in an upregulation of conjugative transfer. Utilizing biparental mating assays, transfer rates of the *traN* knockout strain were determined and compared to that of the pIP501 wild type. The transfer rate of the *E. faecalis* mutant strain (pIP501Δ*traN*) increased by two orders of magnitude (Figure [6A](#F6){ref-type="fig"}). To complement the observed phenotype of the *traN* deletion strain, a plasmid constitutively overexpressing TraN was supplied *in trans*. Interestingly, the elevated transfer frequency observed in the *traN* deletion mutant was not only reverted but overcompensated such that the conjugative transfer was more than two orders of magnitude below wild type levels (Figure [6A](#F6){ref-type="fig"}). Conclusively, *traN* complementation reverted effects of *traN* deletion on gene expression (Figure [6B](#F6){ref-type="fig"}) and steady-state protein levels (Figure [6C](#F6){ref-type="fig"}, [D](#F6){ref-type="fig"}) and also resulted in a significant overcompensation of all analyzed protein levels and most assessed mRNA quantities in respect to wild type cells harboring pIP501.

![*traN* knockout mutant shows increased transfer rates in *E. faecalis* and phenotypic effects of *traN* deletion can be compensated by complementation. (**A**) Results of biparental mating assays monitoring the transfer rate of the *E. faecalis* JH2-2 wild type (pIP501), the mutant strain *E. faecalis* JH2-2 (pIP501Δ*traN*) and the complementation strain, where *traN* is supplied *in trans* (pIP501Δ*traN*, pEU327-*traN*). *n* = 3. (**B**) Analysis of *tra*-gene mRNA levels of cells as described in (A). Relative gene expression was calculated applying the comparative C~T~ method (ΔΔC~T~ Method ([@B37])) using pyrroline-5-carboxylate reductase (*proC)* as housekeeping gene and values are given as fold of the respective wild type gene expression. *n* = 3. (**C, D**) Immunoblot analysis of steady-state protein levels from *E. faecalis* JH2-2 wild type (pIP501), mutant (pIP501Δ*traN*) and complementation (pIP501Δ*traN*, pEU327-*traN*) strain with *E. faecalis* JH2-2 as a negative control. Representative immunoblots (C) and densitometric quantification (D) are shown. Blots were probed with antibodies directed against distinct Tra-proteins and GroEL as loading control. Values are given as fold of the respective wild type protein levels. *n* = 12. Mean (square) and median (center line) are depicted. For dot plots standard error of mean (s.e.m.) is given. n.s. not significant, \**P*\< 0.05, \*\**P*\< 0.01.](gky671fig6){#F6}

Taken together, our results identify TraN as a negative regulator of conjugative transfer, by repressing transcription of pIP501 T4S components, resulting in decreased levels of Tra-proteins, ultimately leading to significantly reduced transfer rates.

A second specific TraN binding site identified on the pIP501 plasmid regulates a promoter directly upstream of the *traN* gene {#SEC3-6}
------------------------------------------------------------------------------------------------------------------------------

In a sequence search for equivalent TraN binding motifs on the pIP501 plasmid, we fixed the identified bases of class (I) interactions in the query sequence. Three additional potential binding sites within the pIP501 plasmid were found and termed BS 2, BS 3 and BS 4. By setting position 8 of the query sequence as variable, we observed another mutated potential binding site (m BS; [Supplementary Table S3](#sup1){ref-type="supplementary-material"}). Conducting further DSF assays, we observed that the thermal stability of TraN was significantly decreased when oligonucleotides comprising the BS 2, BS 4 and m BS sequences were provided, compared to the o BS (Figure [7A](#F7){ref-type="fig"}). Interestingly, providing BS 3 oligonucleotides led to a thermal stability equal to the original site (Figure [7A](#F7){ref-type="fig"}). Furthermore, a potential promoter, termed P*~traNO~*, was found in close proximity to the BS 3 site (Table [2](#tbl2){ref-type="table"}), directly upstream of the *traN* gene. Taken together, these results suggest that the identified BS 3 might represent a potential second binding site for TraN on the pIP501 plasmid. An alignment of all sequences ([Supplementary Figure S6A](#sup1){ref-type="supplementary-material"}) revealed that the observed difference in thermal stability between BS 3 and the other alternative binding sites might be due to the variation of hydrophobic interactions via the methyl groups of thymine bases and by unspecific interactions (class (II) and (III)). Thus, these variations might be caused by the thymine bases at positions 9 and 14 and adenine at position 17. Furthermore, based on the observed van der Waals interactions, we propose that an adenine or a thymine at position 11 is required for the binding specificity ([Supplementary Figure S6A](#sup1){ref-type="supplementary-material"}).

![An alternative TraN binding site on pIP501 regulates a promoter upstream of the *traN* gene. (**A**) Differential scanning fluorimetry (DSF) assay of TraN without DNA, with random DNA and the original binding site (o BS) as well as with alternative binding sites identified on the pIP501 plasmid (m BS, BS 2, BS 3, BS 4). For 'no DNA' *n* = 9, for all others *n* = 10. For a detailed sequence alignment, please see [Supplementary Figure S6A](#sup1){ref-type="supplementary-material"}. (**B**) β-galactosidase assay to monitor promoter activity in *E. coli*. The β-galactosidase gene was set under the control of either the P~*tra*~ promoter with / without the original TraN binding site (o BS) or the P*~traNO~* promoter with / without the alternative specific binding site (BS 3). TraN or the empty vector control were supplied *in trans*. Enzymatic activity was assessed in *E. coli* with a β-galactosidase assay and Miller units are given as fold of the respective empty vector control. *n* = 6. (**C**) Ratio of *traO* mRNA levels to selected *tra*-gene mRNA levels (*traJ, traK* and *traM*). Wild type (pIP501) and mutant cells (pIP501Δ*traN*) were compared to assess the activity of the potential P*~traNO~* promoter and its regulation by TraN by qPCR. mRNA levels were normalized to pyrroline-5-carboxylate reductase (*proC*) as housekeeping gene and the ratio of gene expression is given. *n* = 3. Mean (square) and median (center line) are depicted. For box plots, whiskers show minima and maxima within 2.2 interquartile range (IQR), for dot plots standard error of mean (s.e.m.) is given. n.s. not significant, \**P*\< 0.05, \*\**P*\< 0.01, \*\*\**P*\< 0.001.](gky671fig7){#F7}

###### 

TraN binding motifs on Inc18-like and related multi-resistance plasmids and on bacterial chromosomes. Three different search terms were used: 1: Original binding site (A~6~T~7~G~8~T~9~C~10~A~11~G~12~G~13~T~14~T~15~A~16~A~17~A~18~C~19~A~20~T~21~A~22~T~23~); 2: Binding site involving class (I) interactions (N~6~T~7~G~8~N~9~C~10~N~11~N~12~N~13~N~14~N~15~A~16~N~17~A~18~C~19~A~20~T~21~N~22~N~23)~; 3: Binding site with nucleotides required for TraN specificity (N~6~T~7~G~8~T~9~C~10~A/T~11~N~12~N~13~T~14~N~15~A~16~A~17~A~18~C~19~A~20~T~21~N~22~T~23~)
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To assess the activity of the potential P*~traNO~* promoter in close proximity to the alternative TraN binding site BS 3 just upstream of the *traN* gene, we generated a reporter plasmid carrying the β-galactosidase gene under the control of the potential P*~traNO~* promoter with and without the BS 3 sequence and performed a β-galactosidase assay in *E. coli* (Figure [7B](#F7){ref-type="fig"}). *In trans* expression of TraN revealed a significant and comparable downregulation of β-galactosidase activity when either o BS or BS 3 were available (Figure [7B](#F7){ref-type="fig"}), pointing toward a role of TraN in regulating the identified promoter P*~traNO~* upstream of the *traN* coding region, therefore indicating a potential autoregulation. To analyze the activity of the identified P*~traNO~* promoter in its native environment in *E. faecalis*, the ratios of relative mRNA levels of *traO* to other *tra*-genes were assessed. As *traO* levels were overrepresented compared to the other tested *tra*-genes in the wild type harboring pIP501, as indicated by a ratio higher than one (Figure [7C](#F7){ref-type="fig"}), the P*~traNO~* promoter seems to be active in its native environment under the conditions tested. Interestingly, all calculated ratios were increased upon deletion of *traN*, suggesting that our approach led to the identification of a new promoter in *E. faecalis* and a role of TraN in its regulation.

TraN binding motifs are common in Inc18-like and related multi-resistance plasmids {#SEC3-7}
----------------------------------------------------------------------------------

To identify potential TraN binding sites in related T4SSs, a search for the o BS site as well as for sequences comprising either only class (I) interactions or all nucleotides apparently responsible for specific binding was performed (Table [2](#tbl2){ref-type="table"}). First, the transfer region of the Inc18 family plasmid pRE25, being almost identical to that of pIP501 ([@B51]), was analyzed. Interestingly, while the o BS was present upstream of the origin of transfer (*oriT*), pRE25 lacked BS 3 upstream of the *traN*-like gene (Table [2](#tbl2){ref-type="table"}). Even though we were able to identify a set of potential binding sites (PS 1--5) upstream of the *traN*-homolog ([Supplementary Table S3](#sup1){ref-type="supplementary-material"}), none of these sites revealed increased thermal stability in DSF assays ([Supplementary Figure S6B](#sup1){ref-type="supplementary-material"}). The alignment of the potential binding sites (PS 1--5) with the original site can be found in [Supplementary Figure S6C](#sup1){ref-type="supplementary-material"}.

Additionally, we analyzed other Inc18-like and related multi-resistance plasmids ([Supplementary Table S6](#sup1){ref-type="supplementary-material"}) as well as bacterial strains, where chromosomally encoded homologs of *traN* have been found ([Supplementary Table S7](#sup1){ref-type="supplementary-material"}). Intriguingly, in most cases an o BS-like site near the *oriT* on the leading strand and a BS 3-like site upstream of the *traN*-like gene on the complementary strand - just as on the pIP501 plasmid - was present (Table [2](#tbl2){ref-type="table"} and [Supplementary Tables S6, S7](#sup1){ref-type="supplementary-material"}). Potential promoter sequences were found in close proximity to each binding site (Table [2](#tbl2){ref-type="table"}). On most of these plasmids and bacterial chromosomes, homologs of the relaxase TraA and the motor proteins TraE and TraJ were present ([Supplementary Tables S6, S7](#sup1){ref-type="supplementary-material"}).

DISCUSSION {#SEC4}
==========

The efficient dissemination of conjugative plasmids encoding antibiotic resistances and virulence factors via T4SSs within bacterial communities and across species boundaries represents a major threat to modern healthcare. As the production of the conjugative multi-component machinery responsible for these processes comes with significant energetic costs for bacteria, sophisticated control systems must be in place to minimize these expenses by accurate regulation of *tra*-component expression ([@B52]).

In this study, we establish the small cytosolic protein TraN as an additional repressor of the Inc18-plasmid pIP501. Using X-ray crystallography, we solved the complex structure of TraN bound to its cognate binding site DNA and identified the distinct binding motif. TraN belongs to the family of winged-helix (WH) proteins that can be classified into three types according to their binding modes ([@B53]). The first class of WH proteins comprises the canonical (HNF3-like) DNA interaction profile ([@B54]), where the respective recognition helix contacts the DNA via the major groove. In the second binding mode, represented by the RFX1 transcription factor ([@B55]), the wing recognizes the major groove of the DNA and the recognition helix interacts with the minor groove. The third class, exemplified by PCG2-DBD, involves contacts between the wing and the minor groove, as well as between the recognition helix and the major groove of the target DNA ([@B53]). TraN clearly belongs to the class 1 binding mode and exists as an internal dimer that mostly resembles dimeric transcription factors of the MerR family ([@B16],[@B48]). The wings of TraN are involved in the formation of the hydrophobic interface between the two WH domains of the internal dimer and insert into the central minor groove. A clear difference of TraN to the dimeric transcription regulators of the MerR family that bind palindromic sequences, is the pronounced asymmetry of the two half sites, which is most notable in the DNA contacting residues, thus demanding different DNA recognition motifs. This then leads to an asymmetric DNA binding, as reflected in the observed different binding strengths of the two half sites. The proposed binding asymmetry was verified with differential scanning fluorimetry (DSF) assays, where changing distinct bases in the left binding site (contacted by the C-terminal domain of TraN) led to more pronounced alterations in temperature stability. This asymmetric DNA binding might have functional implications in the regulation of the observed *tra*-component expression or during conjugative DNA transfer, which will be discussed later. Further, a general stabilization of TraN by binding to DNA was observed.

In this study we experimentally validated TraN's proposed role as a repressor of the *tra*-operon. Comparison of steady-state protein levels with data from immunofluorescence analyses in *E. faecalis* revealed a discrepancy in terms of upregulated TraM protein load in the *traN* knockout mutant (pIP501Δ*traN)*. This is most likely due to the fact that only correctly localized TraM on the cell periphery can be detected with the immunofluorescence approach, suggesting that not all of the upregulated protein quantity in the *traN* knockout is properly localized and functional. We selected the VirB8-like protein TraM for immunofluorescence experiments, as it was not only shown to be indispensable for conjugative transfer ([@B56]) but also postulated to be a central member of the MPF complex ([@B49],[@B50],[@B57]). Furthermore, it was demonstrated that localization of TraM was highly dependent on the peptidoglycan-degrading protein TraG, playing an initiatory role in the process of MPF complex assembly ([@B35],[@B38]). Although we demonstrated correct localization of TraM only, it can be assumed that a significant portion of the other upregulated T4S components is also functional in the *E. faecalis traN* knockout, as the transfer rate of the mutant massively increased compared to the wild type strain, clearly demonstrating TraN as a repressor of the pIP501 *tra*-operon.

The higher transfer frequency upon *traN* deletion is most likely caused by the enhanced production of transfer components, as indicated by the elevated Tra-protein load and the increase of TraM-positive foci at the cell periphery. Nevertheless, a role of TraN in regulating conjugative processes directly, potentially decreasing the efficiency of transfer, cannot be excluded at the moment. Furthermore, it is feasible that TraN might exert repression of transfer frequency by downregulation of TraO, a proposed surface adhesin ([@B50],[@B57],[@B58]). As G+ T4SSs lack conjugative pili, they rely on surface adhesins to establish the tight contact between donor and recipient cells ([@B4]). The observed elevated transfer frequencies in the deletion mutant *E. faecalis* pIP501Δ*traN* might thus be caused by an increased number of TraO molecules, giving rise to a better contact to potential recipient cells and/or a contact to more recipients. Indeed, the observed transcriptional activity from the second promoter P*~traNO~*, upstream of the *traN* gene, increased the abundance of *traO* transcripts compared to other *tra*-genes. We could further demonstrate that P*~traNO~* is also regulated by TraN, most probably by TraN binding to the alternative binding site BS 3. The possibility of transcriptional repression via BS 3 might prevent an overproduction of TraN, which would result in a marked downregulation of *tra*-operon production, as observed when overexpressing TraN *in trans* for complementation experiments. Thus, TraN might at least partially autoregulate its own synthesis. Furthermore, the fine-tuning of the transcription of the last gene of the operon, *traO*, might be essential to avoid toxicity by overproduction of surface adhesins, as demonstrated for other systems. ([@B59]). Until now, effects of TraO overexpression on bacterial viability have not been directly investigated, whereas overproduction of PrgB, a surface adhesin from the *E. faecalis* pheromone-responsive plasmid pCF10, was demonstrated to lead to cellular lysis, thus regulation of its synthesis was shown to be necessary ([@B4],[@B59],[@B60]). The observed growth delay and reduced viability of the *E. faecalis traN* deletion mutant might be attributable to overexpression of TraO, leading to toxic effects similar to those seen for PrgB. Thus, the repression of the P*~traNO~* promoter by TraN binding to BS 3 might not only be important for regulation of TraN expression levels but also to maintain TraO levels in a range that ensures optimal transfer activity while minimizing the risk of toxic effects due to overproduction.

While TraN seems to independently regulate this feedback loop at the P*~traNO~* promoter site, transcriptional regulation at the P*~tra~* promoter might be conducted by both the relaxase TraA and TraN. TraA has been shown to autoregulate its own synthesis by binding to an area overlapping with the −10 region of the P*~tra~* promoter ([@B13]) and thus the protein is hypothesized to tune early steps of *tra*-component expression. We further propose that upon reaching a certain threshold level, TraN will occupy its cognate binding sites. This then represses the transcription from the P*~tra~* as well as the P*~traNO~* promoter, accomplished either by spatial hindrance of the transcription machinery or by bending of the DNA. Indeed, such a bend in the DNA can be observed in the TraN-DNA co-crystal structure.

Responding to yet unknown signals from the environment and/or potential recipients, conjugative transfer is initiated by the relaxase TraA, introducing a single strand cut at the *oriT*. Concomitant with conjugative transfer, replication of the plasmid is initiated. Due to TraN's strong interaction with its binding motif, it is conceivable that the protein is only released from the o BS site upstream of the *oriT* when the first steps of conjugation are initiated. In this scenario, TraN might remain bound to the second site upstream of the *traN* gene (BS 3) and is only released upon unwinding of the ds-DNA during the DNA transfer and the concomitant DNA-replication process. Once the ds-DNA has been re-established through replication, TraN might again bind to its cognate binding sites, repressing both the P*~tra~* as well as the P*~traNO~* promoter. This might occur in a way already observed for distinct transcription factors ([@B61]), namely by interaction with unspecific DNA sequences, thus sliding along the ds-DNA until the specific site is reached. This hypothesis is strengthened by the observation that TraN shows relatively strong binding affinity to random DNA, although weaker than to the cognate binding site sequence ([@B16]). When the specific binding site is reached, the C-terminal domain of TraN might contribute substantially to the strong protein--DNA interaction.

In sum, we propose the following mechanism of concerted *tra*-operon regulation by the repressor protein TraN and the relaxase TraA (Figure [8A](#F8){ref-type="fig"}): First, the transcription of the *tra*-operon is initiated. The relaxase TraA, encoded as the very first *tra*-gene, is expressed, binds to its binding site at the P*~tra~* promoter and tunes the level of *tra*-operon transcription. Simultaneously, the other Tra-proteins are produced and the MPF complex assembles at the bacterial membrane. The P*~traNO~* promoter leads to enhanced production of TraN and the surface adhesin TraO. Once TraN protein levels reach a certain threshold, both high affinity binding sites on the pIP501 plasmid will be occupied and transcription repressed. This results in a feedback loop and minimizes the risk of cytotoxicity mediated by overproduction of TraO and/or other Tra-proteins. Responding to yet unknown signals from the recipient or the environment (Figure [8B](#F8){ref-type="fig"}), the first steps of conjugation are initiated. The relaxase TraA nicks the plasmid at the *oriT*, and the unwinding and replication processes of the pIP501 plasmid are started. At this time point, TraN has to be released from its binding site upstream of the *oriT* (o BS) and the plasmid translocation process takes place. TraN might remain bound to its second binding site (BS 3) except for a short time interval during the replication process. Once replication of the plasmid is completed in the donor, TraN again binds to its binding sites at the P*~tra~* and P*~traNO~* promoter and thus further represses transcriptional processes, regulating *tra*-component production. While the exact sequence of *tra*-operon regulation and conjugative processes has not been revealed yet, it can be assumed that those processes are intertwined and well-matched. Thus, conjugative efficiency is optimized, while overshooting production of Tra-proteins is reduced to a minimum.

![Scheme of the proposed regulation of pIP501 by TraN and the relaxase TraA. (**A**) Regulation of *tra*-operon expression by TraN and TraA. (1) The expression of Tra-proteins from the *tra*-operon is initiated and mRNA is produced from the P*~tra~* and the P*~traNO~* promoters. (2) The relaxase TraA binds to its binding site at the P*~tra~* promoter and controls the level of *tra*-operon transcription, while the P*~traNO~* promoter remains active. Simultaneously, Tra-proteins are produced and the mating pair formation (MPF) complex assembles at the bacterial membrane. (3) TraN binding to its binding sites upstream of the P*~tra~* and the P*~traNO~* promoters leads to repression of transcription. (**B**) Initiation of conjugative transfer by the relaxase TraA. Responding to yet unknown signals, conjugative processes are initiated by the relaxase TraA introducing a single-strand (ss) cut at the origin of transfer (*oriT*). TraN is released from its binding site at the P~*tra*~promoter and replication takes place in the donor, while the ss-DNA is transferred to the recipient.](gky671fig8){#F8}

Intriguingly, we could identify further potential TraN binding sites on several Inc18 or related multi-resistance plasmids as well as on bacterial chromosomes. Inc18 plasmids have been demonstrated to be major key players in the dissemination of *vanA*-encoded vancomycin resistance and other determinants facilitating non-susceptibility of MRSA strains to last-line antibiotics ([@B7],[@B50],[@B62],[@B63]). Interestingly, most investigated bacterial plasmids and bacterial chromosomes containing a potential TraN binding site not only encoded a TraN-homolog but also a putative TraA-like relaxase and putative homologs of the motor proteins TraE and TraJ. As all studied plasmids of the Inc18 and related incompatibility groups encoding a *traN* homolog also possess at least one specific putative TraN binding site, we speculate that the regulatory mechanism established for TraN applies to a wide range of systems.

Taken together, we identified TraN as a repressor of conjugative transfer and demonstrate its mode of action, which most probably is conserved across a wide range of Inc18-like and related multi-resistance plasmids responsible for dissemination of antibiotic resistances. We postulate that stimulating the expression of TraN-like proteins or synthetic TraN mimetics might result in diminished horizontal gene transfer not only of pIP501, but rather of a large group of Inc18 or related multi-resistance plasmids. Thus, further studies on TraN and similar T4S regulators might pave the way to efficient interventions decelerating the spreading of antibiotic resistances.
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